CVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance and expects to raise insurance plan prices in the coming year as it adjusts for Medicare ...

For the quarter ended December 2025, CVS Health (CVS) reported revenue of $105.69 billion, up 8.2% over the same period last year. EPS came in at $1.09, compared to $1.19 in the year-ago quarter. The ...

Diversified healthcare company CVS Health (NYSE:CVS) reported in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ ...

CVS Health Corporation's Q1 2025 earnings show strong growth, with revenues up 7% YoY and adjusted EPS up 72%, but caution is advised for the long-term outlook. Despite positive quarterly results, CVS ...

CVS Health has shown impressive year-to-date performance, driven by strong Q1 results and strategic shifts in its business model. I reiterate a buy rating on CVS due to its low valuation, mixed ...